Royal Bank of Canada’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $715M | Sell |
|
|||||
|
2025
Q1 | $855M | Buy |
|
|||||
|
2024
Q4 | $889M | Buy |
|
|||||
|
2024
Q3 | $925M | Buy |
|
|||||
|
2024
Q2 | $737M | Buy |
|
|||||
|
2024
Q1 | $496M | Sell |
|
|||||
|
2023
Q4 | $604M | Sell |
|
|||||
|
2023
Q3 | $709M | Sell |
|
|||||
|
2023
Q2 | $908M | Buy |
|
|||||
|
2023
Q1 | $869M | Sell |
|
|||||
|
2022
Q4 | $1.3B | Buy |
|
|||||
|
2022
Q3 | $1.02B | Sell |
|
|||||
|
2022
Q2 | $1.33B | Sell |
|
|||||
|
2022
Q1 | $1.4B | Sell |
|
|||||
|
2021
Q4 | $1.63B | Buy |
|
|||||
|
2021
Q3 | $1.13B | Buy |
|
|||||
|
2021
Q2 | $993M | Sell |
|
|||||
|
2021
Q1 | $946M | Sell |
|
|||||
|
2020
Q4 | $1B | Buy |
|
|||||
|
2020
Q3 | $910M | Buy |
|
|||||
|
2020
Q2 | $704M | Buy |
|
|||||
|
2020
Q1 | $616M | Buy |
|
|||||
|
2019
Q4 | $692M | Sell |
|
|||||
|
2019
Q3 | $675M | Sell |
|
|||||
|
2019
Q2 | $913M | Sell |
|
|||||
|
2019
Q1 | $959M | Buy |
|
|||||
|
2018
Q4 | $809M | Sell |
|
|||||
|
2018
Q3 | $826M | Sell |
|
|||||
|
2018
Q2 | $714M | Buy |
|
|||||
|
2018
Q1 | $688M | Sell |
|
|||||
|
2017
Q4 | $728M | Buy |
|
|||||
|
2017
Q3 | $585M | Buy |
|
|||||
|
2017
Q2 | $534M | Sell |
|
|||||
|
2017
Q1 | $602M | Sell |
|
|||||
|
2016
Q4 | $678M | Buy |
|
|||||
|
2016
Q3 | $620M | Buy |
|
|||||
|
2016
Q2 | $597M | Sell |
|
|||||
|
2016
Q1 | $590M | Buy |
|
|||||
|
2015
Q4 | $636M | Sell |
|
|||||
|
2015
Q3 | $626M | Buy |
|
|||||
|
2015
Q2 | $592M | Sell |
|
|||||
|
2015
Q1 | $657M | Buy |
|
|||||
|
2014
Q4 | $550M | Buy |
|
|||||
|
2014
Q3 | $475M | Buy |
|
|||||
|
2014
Q2 | $405M | Sell |
|
|||||
|
2014
Q1 | $490M | Sell |
|
|||||
|
2013
Q4 | $532M | Buy |
|
|||||
|
2013
Q3 | $416M | Sell |
|
|||||
|
2013
Q2 | $413M | Buy |
|